Federico Franchi

Prof. Federico Franchi

Emergency-Anesthesia and Intensive Care Unit, Department of Medicine, Surgery and Neurosciences, Santa Maria alle Scotte University Hospital, V.le Bracci 1, 53100 Siena, Italy
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of Critical Care
Verified
Journal Article
Closed access
EAElio Antonucci
Elio Antonucci
EFEnrico Fiaccadori
Enrico Fiaccadori
KDKatia Donadello
Katia Donadello
FTFabio Silvio Taccone
Fabio Silvio Taccone
Federico FranchiFederico Franchi
Federico Franchi
SSSabino Scolletta
Sabino Scolletta

1 March 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
JCJames Coromilas
James Coromilas
SKStephanie Kochav
Stephanie Kochav
IGIsaac Goldenthal
Isaac Goldenthal
ABAngelo Biviano
Angelo Biviano
HGHasan Garan
Hasan Garan
EWElaine Y. Wan
Elaine Y. Wan
Background - COVID-19 has led to over 1 million deaths worldwide and has been associated with cardiac complications including cardiac arrhythmias. The incidence and pathophysiology of these manifestations remain elusive. In this worldwide survey of patients hospitalized with COVID-19 who developed cardiac arrhythmias, we describe clinical characteristics associated with various arrhythmias, as well as global differences in modulations of routine electrophysiology practice during the pandemic. Methods - We conducted a retrospective analysis of patients hospitalized with COVID-19 infection worldwide with and without incident cardiac arrhythmias. Patients with documented atrial fibrillation (AF), atrial flutter (AFL), supraventricular tachycardia (SVT), non-sustained or sustained ventricular tachycardia (VT), ventricular fibrillation (VF), atrioventricular block (AVB), or marked sinus bradycardia (HR<40bpm) were classified as having arrhythmia. De-identified data was provided by each institution and analyzed. Results - Data was collected for 4,526 patients across 4 continents and 12 countries, 827 of whom had an arrhythmia. Cardiac comorbidities were common in patients with arrhythmia: 69% had hypertension, 42% diabetes mellitus, 30% had heart failure and 24% coronary artery disease. Most had no prior history of arrhythmia. Of those who did develop an arrhythmia, the majority (81.8%) developed atrial arrhythmias, 20.7% developed ventricular arrhythmias, and 22.6% had bradyarrhythmia. Regional differences suggested a lower incidence of AF in Asia compared to other continents (34% vs. 63%). Most patients in in North America and Europe received hydroxychloroquine, though the frequency of hydroxychloroquine therapy was constant across arrhythmia types. Forty-three percent of patients who developed arrhythmia were mechanically ventilated and 51% survived to hospital discharge. Many institutions reported drastic decreases in electrophysiology procedures performed. Conclusions - Cardiac arrhythmias are common and associated with high morbidity and mortality among patients hospitalized with COVID-19 infection. There were significant regional variations in the types of arrhythmias and treatment approaches.

31 October 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
CCChiara Catelli
Chiara Catelli
RCRoberto Corzani
Roberto Corzani
EZE. Zanfrini
E. Zanfrini
Federico FranchiFederico Franchi
Federico Franchi
MGMarco Ghisalberti
Marco Ghisalberti
LLL. Luzzi
L. Luzzi

1 November 2012 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
SSSabino Scolletta
Sabino Scolletta
KDKatia Donadello
Katia Donadello
CSCristina Santonocito
Cristina Santonocito
Federico FranchiFederico Franchi
Federico Franchi
FTFabio Silvio Taccone
Fabio Silvio Taccone
Cardiac arrest (CA) is a major health and economic problem. Management of patients resuscitated from CA is challenging for clinicians, and the mortality rate of those who achieve return of spontaneous circulation remains high. Hypoxic brain injury, cardiovascular abnormalities and systemic ischemia/reperfusion response characterize the so-called 'postcardiac arrest syndrome', which could lead to multiple organ failure and poor outcome after CA. The magnitude of these disorders differs in individual patients, mainly based on the cause and duration of CA and on the severity of the ischemic episode. Prognostication of outcome after CA is of importance because it could help physicians on triage decisions and readdress the overall management. A number of factors are thought to influence the prognosis of patients after CA, but due to the heterogeneity of CA population and scenarios no single factor has been identified as a reliable predictor of outcome and the timing and optimal approach to prognostication is still controversial. Biomarkers represent a growing area of interest in this field, as they may provide clinicians with early information on the severity of organ dysfunction to make a decision on clinical strategies and prognosticate outcome. In this article, the authors will focus on cardiac, neurological and inflammatory biomarkers as potential predictors of outcome after CA.

1 May 2021 in Cytokine
Verified
Journal Article
Closed access
laura bergantinilaura bergantini
laura bergantini
EBE. Bargagli
E. Bargagli
Miriana D'AlessandroMiriana D'Alessandro
Miriana D'Alessandro
RRR.M. Refini
R.M. Refini
PCPaolo Cameli
Paolo Cameli
FDF. Dotta
F. Dotta

1 July 2016 in Critical Care Medicine
Verified
Journal Article
Open access
SSSabino Scolletta
Sabino Scolletta
Federico FranchiFederico Franchi
Federico Franchi
SRStefano Romagnoli
Stefano Romagnoli
RCRossella Carlà
Rossella Carlà
ADAbele Donati
Abele Donati
DPDidier Payen
Didier Payen
Objectives: Echocardiography and pulse contour methods allow, respectively, noninvasive and less invasive cardiac output estimation. The aim of the present study was to compare Doppler echocardiography with the pulse contour method MostCare for cardiac output estimation in a large and nonselected critically ill population. Design: A prospective multicenter observational comparison study. Setting: The study was conducted in 15 European medicosurgical ICUs. Patients: We assessed cardiac output in 400 patients in whom an echocardiographic evaluation was performed as a routine need or for cardiocirculatory assessment. Interventions: None. Measurements and Main Results: One echocardiographic cardiac output measurement was compared with the corresponding MostCare cardiac output value per patient, considering different ICU admission categories and clinical conditions. For statistical analysis, we used Bland-Altman and linear regression analyses. To assess heterogeneity in results of individual centers, Cochran Q, and the I 2 statistics were applied. A total of 400 paired echocardiographic cardiac output and MostCare cardiac output measures were compared. MostCare cardiac output values ranged from 1.95 to 9.90 L/min, and echocardiographic cardiac output ranged from 1.82 to 9.75 L/min. A significant correlation was found between echocardiographic cardiac output and MostCare cardiac output (r = 0.85; p < 0.0001). Among the different ICUs, the mean bias between echocardiographic cardiac output and MostCare cardiac output ranged from –0.40 to 0.45 L/min, and the percentage error ranged from 13.2% to 47.2%. Overall, the mean bias was –0.03 L/min, with 95% limits of agreement of –1.54 to 1.47 L/min and a relative percentage error of 30.1%. The percentage error was 24% in the sepsis category, 26% in the trauma category, 30% in the surgical category, and 33% in the medical admission category. The final overall percentage error was 27.3% with a 95% CI of 22.2–32.4%. Conclusions: Our results suggest that MostCare could be an alternative to echocardiography to assess cardiac output in ICU patients with a large spectrum of clinical conditions.